You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial
|
|---|---|
| Published in |
The Lancet, May 2009
|
| DOI | 10.1016/s0140-6736(09)60740-6 |
| Pubmed ID | |
| Authors |
Paul Ellis, Peter Barrett-Lee, Lindsay Johnson, David Cameron, Andrew Wardley, Susan O'Reilly, Mark Verrill, Ian Smith, John Yarnold, Robert Coleman, Helena Earl, Peter Canney, Chris Twelves, Christopher Poole, David Bloomfield, Penelope Hopwood, Stephen Johnston, Mitchell Dowsett, John MS Bartlett, Ian Ellis, Clare Peckitt, Emma Hall, Judith M Bliss, for the TACT Trial Management Group, the TACT Trialists |
Mendeley readers
The data shown below were compiled from readership statistics for 153 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 1% |
| Ecuador | 1 | <1% |
| Costa Rica | 1 | <1% |
| Mexico | 1 | <1% |
| Spain | 1 | <1% |
| Japan | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 145 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 25 | 16% |
| Student > Master | 25 | 16% |
| Other | 20 | 13% |
| Student > Ph. D. Student | 15 | 10% |
| Professor > Associate Professor | 9 | 6% |
| Other | 36 | 24% |
| Unknown | 23 | 15% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 79 | 52% |
| Agricultural and Biological Sciences | 17 | 11% |
| Biochemistry, Genetics and Molecular Biology | 5 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 3% |
| Nursing and Health Professions | 2 | 1% |
| Other | 15 | 10% |
| Unknown | 30 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 July 2018.
All research outputs
#8,533,995
of 25,371,288 outputs
Outputs from The Lancet
#25,991
of 42,669 outputs
Outputs of similar age
#36,972
of 104,025 outputs
Outputs of similar age from The Lancet
#108
of 168 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 42,669 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 67.9. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 104,025 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 168 others from the same source and published within six weeks on either side of this one. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.